Literature DB >> 2642684

Staphylococcal scalded skin syndrome mimicking acute graft-vs-host disease in a bone marrow transplant recipient.

N S Goldberg1, T Ahmed, B Robinson, J Ascensao, H Horowitz.   

Abstract

A 33-year-old man with mild acute graft-vs-host disease after an allogeneic bone marrow transplant for chronic myelogenous leukemia developed a necrolytic rash 90 days after transplant. A diagnosis of staphylococcal scalded skin syndrome was made when a skin biopsy specimen revealed a split in the granular layer and phage group 2, type 71 Staphylococcus aureus was cultured from the blood.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642684

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Nasal, axillary, and perineal carriage of Staphylococcus aureus among women: identification of strains producing epidermolytic toxin.

Authors:  S J Dancer; W C Noble
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

2.  Host resistance to Listeria monocytogenes infection is enhanced but resistance to Staphylococcus aureus infection is reduced in acute graft-versus-host disease in mice.

Authors:  T Miura; D Mizuki; S Sasaki; S Hasegawa; H Sashinami; A Nakane
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Development and evaluation of detection systems for staphylococcal exfoliative toxin A responsible for scalded-skin syndrome.

Authors:  S Ladhani; S Robbie; R C Garratt; D S Chapple; C L Joannou; R W Evans
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

Review 4.  Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.

Authors:  S Ladhani; C L Joannou; D P Lochrie; R W Evans; S M Poston
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

5.  Staphylococcal scalded skin syndrome in an immunocompromised adult.

Authors:  E Roeb; T Schönfelder; S Matern; H G Sieberth; W Lenz; R Lütticken; R R Reinert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.